Company: FVN
Filing Date: 2025-05-02
Form Type: S-4
Source: 0001829126-25-003304
Chunk: 79

Company: Future Vision II Acquisition Corp.
Filing Date: 2025-05-02
Form: S-4
Chunk 79
---
 domestic U.S. issuer, which may limit the information publicly available to New VIWO’s shareholders. |

| ● | As a foreign private issuer, we are permitted to adopt certain home country practices in relation to corporate governance matters that differ significantly from the Nasdaq listing standards. These practices may afford less protection to shareholders than they would enjoy if we complied fully with corporate governance listing standards. |

<div align='center'>40</div>

Risks Related to New VIWO’s ordinary shares and Organizational Structure

| ● | The price of New VIWO’s ordinary shares likely will be volatile like the shares of other early-stage companies. |

| ● | If the Business Combination’s benefits do not meet the expectations of investors or securities analysts, the market price of our securities may decline. |

| ● | If securities or industry analysts do not publish research or publish unfavorable research about our business, our share price and trading volume could decline. |

| ● | We may fail to realize any or all of the anticipated benefits of the Business Combination. |

| ● | We have broad discretion in the use of our existing cash, cash equivalents and the net proceeds from the Business Combination and may not use them effectively. |

| ● | VIWO has never paid dividends on its ordinary shares, and New VIWO does not anticipate paying any cash dividends on our ordinary shares in the foreseeable future. |

| ● | Sales of a substantial number of our securities in the public market by our existing shareholders could cause our share price to decline. |

| ● | The right agreement designate the courts of the State of New York or the United States District Court for the Southern District of New York as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by holders of our rights, which could limit the ability of right holders to obtain a favorable judicial forum for disputes with our company. |

| ● | New VIWO will have a controlling Shareholder whose interests may differ from those of its public Shareholders. |

| ● | If New VIWO meets the definition of a “controlled company” under the rules of the Nasdaq Listing Rule, it may choose to exempt from certain corporate governance requirements that could have an adverse effect on the public shareholders. |

| ● | Because New VIWO may be a “controlled company” following the Business Combination under The Nasdaq Stock Market listing standards, our Shareholders may not have certain corporate governance protections that are available to Shareholders of companies that are not controlled companies. |

<div align='center'>41</div>

SUM